322 related articles for article (PubMed ID: 30515172)
1. Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.
Domenech M; Sempere J; de Miguel S; Yuste J
Front Immunol; 2018; 9():2700. PubMed ID: 30515172
[TBL] [Abstract][Full Text] [Related]
2. Respiratory tract infections in the immunocompromised.
Godbole G; Gant V
Curr Opin Pulm Med; 2013 May; 19(3):244-50. PubMed ID: 23508112
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community.
Larsson M; Kronvall G; Chuc NT; Karlsson I; Lager F; Hanh HD; Tomson G; Falkenberg T
Trop Med Int Health; 2000 Oct; 5(10):711-21. PubMed ID: 11044266
[TBL] [Abstract][Full Text] [Related]
4. [New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation].
Richter DC; Brenner T; Brinkmann A; Grabein B; Hochreiter M; Heininger A; Störzinger D; Briegel J; Pletz M; Weigand MA; Lichtenstern C
Anaesthesist; 2019 Nov; 68(11):785-800. PubMed ID: 31555832
[TBL] [Abstract][Full Text] [Related]
5. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.
van Houten CB; Oved K; Eden E; Cohen A; Engelhard D; Boers S; Kraaij R; Karlsson R; Fernandez D; Gonzalez E; Li Y; Stubbs A; Moore ERB; Hays JP; Bont LJ
BMC Infect Dis; 2018 Aug; 18(1):377. PubMed ID: 30086729
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic options for respiratory tract infections.
Bassetti M; Righi E; Carnelutti A
Curr Opin Infect Dis; 2016 Apr; 29(2):178-86. PubMed ID: 26871402
[TBL] [Abstract][Full Text] [Related]
7. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children.
Jacobs MR
Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S109-19. PubMed ID: 14566997
[TBL] [Abstract][Full Text] [Related]
8. [Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections].
Aguado-García JM; Martín-Herrero JE; Lumbreras-Bermejo C
Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):230-7. PubMed ID: 15056440
[TBL] [Abstract][Full Text] [Related]
9. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.
Pennini ME; De Marco A; Pelletier M; Bonnell J; Cvitkovic R; Beltramello M; Cameroni E; Bianchi S; Zatta F; Zhao W; Xiao X; Camara MM; DiGiandomenico A; Semenova E; Lanzavecchia A; Warrener P; Suzich J; Wang Q; Corti D; Stover CK
Nat Commun; 2017 Dec; 8(1):1991. PubMed ID: 29222409
[TBL] [Abstract][Full Text] [Related]
10. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.
Vázquez R; García E; García P
Front Immunol; 2018; 9():2252. PubMed ID: 30459750
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic resistance: infections of the upper respiratory tract and bronchi. When are antibiotics necessary?].
Zellweger C; Täuber MG
Ther Umsch; 2002 Jan; 59(1):21-9. PubMed ID: 11851042
[TBL] [Abstract][Full Text] [Related]
12. Microbiology of bacterial respiratory infections.
Cappelletty D
Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S55-61. PubMed ID: 9727651
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.
Munguia J; Nizet V
Trends Pharmacol Sci; 2017 May; 38(5):473-488. PubMed ID: 28283200
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of upper respiratory tract infections in the primary care setting.
Fendrick AM; Saint S; Brook I; Jacobs MR; Pelton S; Sethi S
Clin Ther; 2001 Oct; 23(10):1683-706. PubMed ID: 11726004
[TBL] [Abstract][Full Text] [Related]
15. Targeting antimicrobial-resistant bacterial respiratory tract pathogens: it is time to 'get smart'.
Lee B; Boucher HW
Curr Opin Pulm Med; 2015 May; 21(3):293-303. PubMed ID: 25784248
[TBL] [Abstract][Full Text] [Related]
16. [Sense and nonsense in antibiotic therapy for respiratory tract infections].
Domej W; Flögel E; Tilz GP; Demel U
Internist (Berl); 2005 Jul; 46(7):795-9. PubMed ID: 15815891
[TBL] [Abstract][Full Text] [Related]
17. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Lode H
Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
[TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
